Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01451255 · ClinicalTrials.gov registry record
Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging
A clinical trial, sponsored by Mayo Clinic.
- Completed
- Registry status
- 90
- Enrollment target
NCT01451255: Completed study, sponsored by Mayo Clinic.
NCT01451255 is a clinical trial that has completed, run by Mayo Clinic. The registered enrollment target is 90 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01451255 has completed, sponsored by Mayo Clinic.
- COMPLETED
- Registry status
- 90 participants
- Enrollment target
Study Summary
Cardiac magnetic resonance imaging has emerged as a potential valuable test for the early detection of Pulmonary Arterial Hypertension. A number of reports have provided some preliminary evidence that Pulmonary Artery (PA) stiffness may be accurately detected by imaging of the pulmonary artery in order to measure PA stiffness. In addition, cardiac MRI could play provide early and effective treatment for Pulmonary Arterial Hypertension (PAH).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 90 participants |
| Start Date | 2011-08 |
| Est. Completion | 2014-06 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01451255
The ClinicalTrials.gov registry entry for NCT01451255 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 90 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Mayo Clinic, which has 2,844 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01451255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01451255 about?
NCT01451255 is a clinical study titled "Early Detection of Pulmonary Arterial Hypertension Using Cardiac Magnetic Resonance Imaging". Cardiac magnetic resonance imaging has emerged as a potential valuable test for the early detection of Pulmonary Arterial Hypertension. A number of reports have provided some preliminary evidence that Pulmonary Artery (PA) stiffness may be accurately detected by imaging of the pulmonary artery in or...
What is the current status of trial NCT01451255?
This trial is currently completed. The enrollment target is 90 participants. The study started on 2011-08. Estimated completion is 2014-06.
Who is sponsoring clinical trial NCT01451255?
This trial is sponsored by Mayo Clinic, which has 2,844 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.